Canaday David H
Division of Infectious Disease, Case Western Reserve University, Cleveland, OH, USA.
Methods Mol Biol. 2013;960:297-307. doi: 10.1007/978-1-62703-218-6_22.
T cell hybridomas are very useful tools to investigate antigen presenting cell (APC) function. They were developed based on the fusion technology that led to monoclonal antibody section. Antigen-specific primary T cells are generated and fused to an immortal thymoma line. Unfused thymoma cells are eliminated by engineered metabolic selection. Antigen-specific hybridomas are identified and may be characterized in detail. Primary T cells are preferable for studies of the regulatory mechanisms intrinsic to T cells, but for study of antigen presentation T cell hybridomas have advantages over primary T cell clones, including their relative uniformity, stability over time, and ready availability in large numbers for extensive antigen presentation experiments.
T细胞杂交瘤是研究抗原呈递细胞(APC)功能的非常有用的工具。它们是基于导致单克隆抗体产生的融合技术而开发的。产生抗原特异性的原代T细胞,并将其与永生性胸腺瘤细胞系融合。未融合的胸腺瘤细胞通过工程化代谢选择被清除。鉴定出抗原特异性杂交瘤,并可对其进行详细表征。原代T细胞对于研究T细胞内在的调节机制是优选的,但对于抗原呈递的研究,T细胞杂交瘤比原代T细胞克隆具有优势,包括它们相对的一致性、随时间的稳定性以及大量可随时获得以进行广泛的抗原呈递实验。